Clinical trial
Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas
NCT00002876 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00002876 |
|---|---|
| Title | Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas |
| Official title | A PHASE II TRIAL OF ETOPOSIDE AND CISPLATIN IN THE TREATMENT OF RECURRENT EPENDYMOMAS |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | cisplatin, etoposide |
| Enrollment | 35 |
| Start date | Oct 1, 1991 |
| Primary completion | Apr 1, 1998 |
| Completion | Jan 1, 2005 |
| First posted | May 21, 2004 |
| Last update posted | May 11, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: